Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack

NCT00330850 is registered in ClinicalTrials.gov with ProEthic Pharmaceuticals as lead sponsor.

NCT NCT00330850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack
Lead sponsor
ProEthic Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2006
Completion date
December 31, 2006
Enrollment
650
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

migraine, phonophobia, photophobia